Turitz Andrew 4
4 · Teladoc Health, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Turitz Andrew
SVP - Business Development
Transactions
- Sale
Common Stock
2024-03-01$15.06/sh−475$7,154→ 25,193 total - Exercise/Conversion
Common Stock
2024-03-01+4,226→ 29,419 total - Exercise/Conversion
Common Stock
2024-03-01+437→ 29,856 total - Exercise/Conversion
Common Stock
2024-03-01+867→ 30,723 total - Exercise/Conversion
Common Stock
2024-03-01+1,348→ 32,071 total - Exercise/Conversion
Common Stock
2024-03-01+12,400→ 44,471 total - Exercise/Conversion
Common Stock
2024-03-01+1,148→ 45,619 total - Sale
Common Stock
2024-03-04$14.52/sh−6,190$89,854→ 39,429 total - Award
Performance Stock Units
2024-03-01+12,679→ 12,679 total→ Common Stock (12,679 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−4,226→ 8,453 total→ Common Stock (4,226 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−437→ 0 total→ Common Stock (437 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−867→ 0 total→ Common Stock (867 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−1,348→ 5,392 total→ Common Stock (1,348 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−12,400→ 24,802 total→ Common Stock (12,400 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−1,148→ 0 total→ Common Stock (1,148 underlying)
Footnotes (13)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 27, 2023.
- [F10]On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
- [F11]On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F12]On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F13]On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- [F2]Performance stock units convert to shares of TDOC common stock on a one-for-one basis
- [F3]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F4]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F5]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- [F6]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
- [F7]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F8]On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F9]On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.